FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for olmesartan medoxomil (ANDA 203281), a generic antihypertensive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)